BeiGene Announces Acceptance of Supplemental Import Drug Application in China for ABRAXANE® in Metastatic Pancreatic Cancer - Associated Press https://t.co/hn8FX0QURd
— IDRO (@IDROOhio) May 31, 2019
from Twitter https://twitter.com/IDROOhio
May 30, 2019 at 10:02PM
No comments:
Post a Comment